Data / Form D filings / NewLimit, Inc.
NewLimit, Inc.: Form D filings
NewLimit, Inc., a biotechnology company in South San Francisco, CA, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on May 15, 2025, reports $129.8 million sold of a $130 million offering to 38 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 901 Gateway Boulevard, South San Francisco, CA, 94080
- Phone
- (415) 603-9539
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1977037
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | New notice | $129,999,762 | $129,799,764 | $199,998 | 38 | May 2, 2025 | sec.gov |
| Jan 7, 2025 | Amendment | $72,245,500 | $72,245,500 | 21 | May 8, 2023 | sec.gov | |
| May 17, 2023 | New notice | $72,245,500 | $59,995,503 | $12,249,997 | 19 | May 8, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Armstrong | Director | |
| Zavain Dar | Director | |
| Jacob Kimmel | Executive Officer, Director | |
| Blake Byers | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 12, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NewLimit, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.